Приказ основних података о документу

dc.creatorJevtović, Đorđe
dc.creatorDragović, Gordana
dc.creatorSalemović, Dubravka
dc.creatorRanin, Jovan
dc.creatorKusić, Jovana
dc.creatorMarinković, Jelena
dc.creatorĐurković-Đaković, Olgica
dc.date.accessioned2021-04-20T12:40:23Z
dc.date.available2021-04-20T12:40:23Z
dc.date.issued2014
dc.identifier.issn0753-3322
dc.identifier.urihttp://rimi.imi.bg.ac.rs/handle/123456789/589
dc.description.abstractIntroduction: We evaluated the effects of highly-active-antiretroviral-therapy (HAART) in a resource-limited settings. Methods: A cross-sectional study was performed in patients who had initiated HAART at the HIV/AIDS-Center, Belgrade, Serbia. Treatment response was considered favorable in case of the achievement of undetectable HIVRNA plasma-viral-load (pVL lt 50 copies/mu L), and with the CD4+ T-cell counts increased above 350 cells/mu L. The treatment failure was defined as pVL over 1.7 log(10) copies/mL, regardless of immunological improvement. Results: Eight hundred and forty HIV infected patients were followed-up for 8.2 +/- 3.4 years. Out of 697 patients available for follow-up, 113 (16.2%) patients died, 44 (6.3%) experienced treatment failure, while 540 (77.5%) had sustained undetectable viremia. In 419 (60.1%) favorable treatment response was achieved, while the dissociation between immunological and virological responses to HAART occurred in 121 (14.4%). A baseline CD4+ T-cell counts above 200 cells/mL was the single independent predictor of a favorable treatment response (HR = 2, 95%CI = 1.69-2.61, P = 0.001), while pre-treatment with ART, HCV co-infection and AIDS at the time of treatment initiation, were all factors preventing a favorable response (HR = 0.27, 95% CI = 0.19-0.36, P = 0.001; HR = 0.75, 95% CI = 0.56-0.95, P = 0.02; HR = 0.73, 95% CI = 0.17-0.95, P = 0.018, respectively). A sustained viral suppression was an independent predictor of survival (HR = 0.2, 95% CI 0.07-0.61, P = 0.004). HAART treated HIV-infected patients who reach and maintain undetectable viremia, have an 80% probability of a 14-years survival (P = 0.08, log-rank). Conclusion: If patient with advanced HIV-related immunodeficiency reach and maintain optimal viral suppression during HAART, regardless of the level of immune recovery, and if they continue to maintain this, their prognosis may be fairly good even in the resource-limited settings.en
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41019/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175024/RS//
dc.rightsrestrictedAccess
dc.sourceBiomedicine & Pharmacotherapy
dc.subjectHIVen
dc.subjectHAARTen
dc.subjectSurvivalen
dc.subjectResource limited settingsen
dc.titleTreatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Studyen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage395
dc.citation.issue3
dc.citation.other68(3): 391-395
dc.citation.rankM22
dc.citation.spage391
dc.citation.volume68
dc.identifier.doi10.1016/j.biopha.2014.01.001
dc.identifier.pmid24486106
dc.identifier.scopus2-s2.0-84899485368
dc.identifier.wos000335395400020
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу